Caricamento quotazioni...
Previsioni
Il prezzo obiettivo medio degli analisti è 41,62€ (+53,64%). La mediana è 41,62€ (+53,64%).
| Acquista |
5 |
| Mantieni |
0 |
| Vendi |
0 |
Notizie Vai al feed delle notizie
Electromed beats earnings expectations for Q4, stock weighed down by slight revenue miss and CEO resignation
Electromed reported diluted earnings per share of $0.39 for Q4, beating the $0.31 estimate, while revenue of $19.41 million narrowly missed projections. Fiscal 2026 marked the 15th consecutive quarter of revenue and earnings growth; annual revenue rose to $73.8 million and gross margin improved to 78.5%. The stock fell about 3.5% after the report as investors reacted to the revenue shortfall, a 29% decline in hospital revenue and the announced CEO resignation in April 2027. Management forecasts double‑digit revenue growth for 2027, continued operating leverage, and plans to expand sales and pursue further operational initiatives. » Altro su de.investing.com
Electromed: CEO Jim Cunniff to retire on April 2, 2027
Jim Cunniff, president and CEO of Electromed, announced that he will retire on April 2, 2027 and will resign his seat on the board of directors. The board has engaged an executive search firm to conduct a nationwide search for his successor. Cunniff has held his current position since 2023; Electromed manufactures, among other products, the SmartVest Airway Clearance System. » Altro su de.investing.com
Electromed expects quarterly results with rising revenue and earnings estimates
Electromed will open the books for the quarter ended June 30, 2026 on August 25, 2026. Three analysts forecast on average an EPS of $0.317 (prior year $0.250) and revenues of around $19.3 million (+11.2% versus $17.4 million). For the just-ended fiscal year, the consensus is earnings per share of $1.22 (previously $0.85) and revenue of about $73.6 million (prior year $64.0 million). » Altro su finanzen.net
Dividendi storici Dividendi
Tutte le metriche sui dividendi Tutte le metricheDati finanziari dell'azienda
| (EUR) | giu 2026 | |
|---|---|---|
| Ricavi | 17.01m | 15,29% |
| Utile lordo | 13.39m | 15,86% |
| Utile netto | 2.98m | 59,36% |
| EBITDA | 3.59m | 18,45% |
Dati fondamentali
| Metrica | Valore |
|---|---|
Capitalizzazione di mercato | 214.15m€ |
Numero di azioni | 8.28m |
Massimo/minimo a 52 settimane | 40,67€ - 19,74€ |
| Dividendi | No |
Beta | 0,51 |
Rapporto P/E | 22,00 |
Rapporto PEG | 0,40 |
Rapporto P/B | 4,62 |
Rapporto P/S | 3,38 |
Profilo aziendale
Electromed, Inc. entwickelt, produziert, vermarktet und verkauft Atemwegstherapien und verwandte Produkte, die Hochfrequenz-Brustwand-Oszillationstherapie (HFCWO) in der pulmonalen Versorgung von Patienten verschiedenen Alters in den Vereinigten Staaten und international anwenden. Das Unternehmen bietet das SmartVest Airway Clearance System, das SmartVest SQL System, das aus einem aufblasbaren Therapiekleidungsstück, einem programmierbaren Luftimpulsgenerator und einem patentierten Einzelschlauch besteht, der Luftimpulse vom Generator zum Kleidungsstück liefert, sowie SmartVest Connect, eine drahtlose Technologie mit personalisiertem HFCWO-Therapiemanagementportal für Patienten mit eingeschränkter Lungenfunktion. Darüber hinaus bietet das Unternehmen SmartVest- und SmartVest Wrap-Produkte für den Einmalgebrauch für Gesundheitsdienstleister in der Akutversorgung an. Das Unternehmen bietet seine Produkte vor allem in der häuslichen Pflege für Patienten mit Bronchiektasen, zystischer Fibrose und neuromuskulären Erkrankungen an. Electromed, Inc. vertreibt seine Produkte hauptsächlich an Ärzte und Gesundheitsdienstleister sowie direkt an Patienten. Das Unternehmen wurde 1992 gegründet und hat seinen Hauptsitz in New Prague, Minnesota.
| Nome | ELECTROMED INC. DL -,001 |
| CEO | James L. Cunniff |
| Sede centrale | New Prague,
mn Stati Uniti |
| Sito web | |
| Settore | Sanità |
| Industria | Attrezzature e forniture sanitarie |
| Quotazione in borsa | 13/08/2010 |
| Dipendenti | 195 |
Simboli di borsa
| Borsa | Simbolo |
|---|---|
AMEX | ELMD |
Scopri gli asset
Gli azionisti di ELECTROMED INC. DL -,001 investono anche nei seguenti asset









